Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?Citation formats

  • External authors:
  • Marie A D Haverkort
  • Jeroen B van de Kamer
  • Bradley R Pieters
  • Caro C E Koning
  • Marcel van Herk
  • Geertjan van Tienhoven

Standard

Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit? / Van Herk, Marcel; Haverkort, Marie A D; van de Kamer, Jeroen B; Pieters, Bradley R; Koning, Caro C E; van Herk, Marcel; van Tienhoven, Geertjan.

In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Vol. 105, No. 2, 11.2012.

Research output: Contribution to journalArticle

Harvard

Van Herk, M, Haverkort, MAD, van de Kamer, JB, Pieters, BR, Koning, CCE, van Herk, M & van Tienhoven, G 2012, 'Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 105, no. 2. https://doi.org/10.1016/j.radonc.2012.10.003

APA

Van Herk, M., Haverkort, M. A. D., van de Kamer, J. B., Pieters, B. R., Koning, C. C. E., van Herk, M., & van Tienhoven, G. (2012). Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 105(2). https://doi.org/10.1016/j.radonc.2012.10.003

Vancouver

Van Herk M, Haverkort MAD, van de Kamer JB, Pieters BR, Koning CCE, van Herk M et al. Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit? Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012 Nov;105(2). https://doi.org/10.1016/j.radonc.2012.10.003

Author

Van Herk, Marcel ; Haverkort, Marie A D ; van de Kamer, Jeroen B ; Pieters, Bradley R ; Koning, Caro C E ; van Herk, Marcel ; van Tienhoven, Geertjan. / Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?. In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012 ; Vol. 105, No. 2.

Bibtex

@article{52b80c44245341da83c1f2a3346a8730,
title = "Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?",
abstract = "With daily portal images and repeated CT scans from 20 patients with gold markers (GM) an adaptive margin radiotherapy strategy (AMRT) was simulated and compared to traditional bony anatomy (BA) and standard GM verification protocols. AMRT is comparable with BA. GM protocols are superior.",
author = "{Van Herk}, Marcel and Haverkort, {Marie A D} and {van de Kamer}, {Jeroen B} and Pieters, {Bradley R} and Koning, {Caro C E} and {van Herk}, Marcel and {van Tienhoven}, Geertjan",
year = "2012",
month = "11",
doi = "10.1016/j.radonc.2012.10.003",
language = "English",
volume = "105",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier BV",
number = "2",

}

RIS

TY - JOUR

T1 - Adaptive margin radiotherapy for patients with prostate carcinoma: what's the benefit?

AU - Van Herk, Marcel

AU - Haverkort, Marie A D

AU - van de Kamer, Jeroen B

AU - Pieters, Bradley R

AU - Koning, Caro C E

AU - van Herk, Marcel

AU - van Tienhoven, Geertjan

PY - 2012/11

Y1 - 2012/11

N2 - With daily portal images and repeated CT scans from 20 patients with gold markers (GM) an adaptive margin radiotherapy strategy (AMRT) was simulated and compared to traditional bony anatomy (BA) and standard GM verification protocols. AMRT is comparable with BA. GM protocols are superior.

AB - With daily portal images and repeated CT scans from 20 patients with gold markers (GM) an adaptive margin radiotherapy strategy (AMRT) was simulated and compared to traditional bony anatomy (BA) and standard GM verification protocols. AMRT is comparable with BA. GM protocols are superior.

U2 - 10.1016/j.radonc.2012.10.003

DO - 10.1016/j.radonc.2012.10.003

M3 - Article

VL - 105

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - 2

ER -